Do polymer-free stents coated on-site with rapamycin prevent restenosis?
A novel dose-adjustable, polymer-free, on-site rapamycin-coated stent system is feasible and provides dose-dependent restenosis prevention.
The placement of polymer-free stents coated on-site with rapamycin is feasible and safe. Furthermore, a dose-dependent efficacy in restenosis prevention is achievable with this new DES concept.
Hausleiter et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: